ASYLIA
Dead / Abandoned — Abandoned — no statement of use filed (as of 25 Dec 2023)
What this means for you
This application is over — abandoned 25 Dec 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88691683
- Mark type
- Design + words
- Filed
- 13 Nov 2019
- Published for opposition
- 29 Sept 2020
- Abandoned
- 25 Dec 2023
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and therapeutic preparations for treatment of cancer, auto-immune and infectious diseases
Owner
- Asylia Therapeutics, Inc., Houston, TX, US
- Asylia Therapeutics, Inc., Houston, TX, US
Prosecution history
- 26 Dec 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 25 Dec 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 25 May 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 May 2023 — SOU EXTENSION 5 GRANTED
- 19 May 2023 — SOU EXTENSION 5 FILED
- 19 May 2023 — SOU TEAS EXTENSION RECEIVED
- 29 Mar 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Mar 2023 — SOU EXTENSION 4 GRANTED
- 25 Nov 2022 — SOU EXTENSION 4 FILED
- 27 Mar 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 02 Feb 2023 — NOTICE OF REVIVAL - E-MAILED
- 01 Feb 2023 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 01 Feb 2023 — PETITION TO REVIVE-GRANTED
- 01 Feb 2023 — TEAS PETITION TO REVIVE RECEIVED
- 18 Jan 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED